Breaking News:

PharmaEssentia Gets FDA Approval for Rare Blood Disease

News

Taiwan Biotech PharmaEssentia Gets FDA Approval for Rare Blood Disease

The U.S. Food and Drug Administration last Friday granted approval for Besremi (ropeginterferon alfa-2b-njft) injection for treatments of...

Johnson and Johnson Breaksup with Consumer Health Unit 💔

Johnson & Johnson said it plans to spin off its consumer health unit that markets Baby Powder and Listerine to concentrate on...

Top 5 Biotech Stocks on Reddit October Edition

Biotech is one of the most expensive industries in the world, and prospectively it will keep advancing as the world knows new age of...

Market

Pharma

FDA Greenlights Jazz Pharmaceutical's Xywav for Idiopathic Hypersomnia

FDA approves first of its kind indication for chronic sleep disorder treatment The U.S. Food and Drug Administration on August 12 grants...

FDA Greenlights First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes

The U.S. Food and Drug Administration on July 28 announced the approval of the first interchangeable biosimilar insulin product aimed at...

FDA Questions Safety of Roxadustat Ahead of AdComm Review

FibroGen and AstraZeneca have been pushing for a better heart safety profile for their likely top-of-the-shelf anemia med roxadustat...

Opinion

Jul 4, 2021
3 min

Is Elon Musk's startup Neuralink the Future of Tech in Healthcare?

Have you ever imagined the possibility of using your smartphone with your brain? Like, being able to operate your device with your mind,...

May 23, 2021
2 min

Pfizer and Moderna Are One of the Most ❤️ Companies in the US

Americans appreciate their vaccine makers. Cases in point? Moderna and Pfizer leapfrogged into the top 10 favorite companies in the U.S....

Feb 27, 2021
2 min

It took a Pandemic for Americans to look up to Big Pharma

Nearly two-thirds of Americans now give the Pharma industry a thumbs up. According to The Harris Poll surveys, it is a massive reversal...

Money

Nov 19, 2021
2 min

Taiwan Biotech PharmaEssentia Gets FDA Approval for Rare Blood Disease

The U.S. Food and Drug Administration last Friday granted approval for Besremi (ropeginterferon alfa-2b-njft) injection for treatments of...

Oct 9, 2021
2 min

AI Startup Exscientia Gets $304.7 Million Upsizing of Initial Public Offering 💸📈

Exscientia plc, an Artificial Intelligence firm focused on discovering, designing and developing the highest quality medications in the...

Sep 11, 2021
3 min

Replicate Bioscience Liftoffs with $40 Million in Series A Funding to Develop srRNA Technology

Life sciences venture firm TP on Wednesday announced the launch of Replicate Bioscience in a bid to replicating the success RNA...

Intelligence

Oct 20, 2021
2 min

Top 5 Biotech Stocks on Reddit October Edition

Biotech is one of the most expensive industries in the world, and prospectively it will keep advancing as the world knows new age of...

Oct 11, 2021
3 min

Merck Applies EUA for Antiviral Molnupiravir

Merck (NYSE: MRK) referred to as MSD outside U.S. and Canada, and Ridgeback Biotherapeutics last Friday made it known that Molnupiravir...

Aug 1, 2021
3 min

U.S. SEC Mandates Chinese IPO Hopefuls to Provide Additional Risk Disclosures

The U.S. securities regulator in an exclusive report released on July 30 says it will not allow Chinese companies to undertake...

Breaking News:

News

Taiwan Biotech PharmaEssentia Gets FDA Approval for Rare Blood Disease

Johnson and Johnson Breaksup with Consumer Health Unit 💔

Top 5 Biotech Stocks on Reddit October Edition

Market

Pharma

FDA Greenlights Jazz Pharmaceutical's Xywav for Idiopathic Hypersomnia

FDA Greenlights First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes

FDA Questions Safety of Roxadustat Ahead of AdComm Review

Opinion

Is Elon Musk's startup Neuralink the Future of Tech in Healthcare?

Pfizer and Moderna Are One of the Most ❤️ Companies in the US

It took a Pandemic for Americans to look up to Big Pharma

Money

Taiwan Biotech PharmaEssentia Gets FDA Approval for Rare Blood Disease

AI Startup Exscientia Gets $304.7 Million Upsizing of Initial Public Offering 💸📈

Replicate Bioscience Liftoffs with $40 Million in Series A Funding to Develop srRNA Technology

Intelligence

Top 5 Biotech Stocks on Reddit October Edition

Merck Applies EUA for Antiviral Molnupiravir

U.S. SEC Mandates Chinese IPO Hopefuls to Provide Additional Risk Disclosures

Subscribe to Our Newsletter

Support Journalism